US 8309525
Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
granted A61KA61K38/1709A61K38/1716
Quick answer
US patent 8309525 (Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof) held by The Regents of the University of California expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/1709, A61K38/1716, A61P, A61P3/10